Publication: 4479

Publication: 4479

Updated Results of CABINET Trial/Alliance A021602: Cabozantinib Versus Placebo for Advanced Neuroendocrine Tumors (NET) after Progression on Prior Therapy

URL

Google Scholar

Citation:

Meeting Instance:: NANETS 2024
Year:: 2024
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:: Exelixis;
Grants:: U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN), U10CA180868 (NRG), U10CA180888 (SWOG)

Corr. Author:
Authors:: Thorvardur R Halfdanarson Susan Geyer Tyler Zemla Michael V Knopp Spencer Behr Sydney Pulsipher Fang-Shu Ou Jared Acoba Ardaman Shergill Edward M Wolin Bhavana Konda Nikolaos A Trikalinos Bernard Tawfik Nitya Raj Shagufta Shaheen Namrata Vijayvergia Arvind Dasari Jonathan R Strosberg Elise C Kohn Matthew H Kulke Eileen M O'Reilly Jeffrey A Meyerhardt Jennifer A Chan

Networks:

Study: Alliance-A021602
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: